Navigation Links
ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
Date:10/21/2013

SUNNYVALE, Calif., Oct. 21, 2013 /PRNewswire/ -- ARRAYit Corporation (OTCQB: ARYC) has shipped its proprietary life sciences products to search engine giant Google Inc. (NASDAQ: GOOG). ARRAYit is a microarray technology leader offering platforms, instruments, tools, kits and reagents to empower human genome discoveries including the ability to decipher all 6,000 human diseases.

Genomic and proteomic information generated using the ARRAYit platform benefits from intensive computational capacity and advanced mathematical algorithms analogous to those used for Internet search. This creates a natural fit between the ARRAYit Microarray Platform and Google. In 2009, Google had invested $7 million in the consumer genetics firm 23andMe, which uses microarray technology to deliver health, disease and ancestry information to the public.

Earlier this year, ARRAYit proposed a consumer testing opportunity to Facebook Inc., further underscoring the perceived synergy between life sciences companies and Internet search and social networking. In 2012, Google reported $50.1 billion in revenue, $10.7 billion in net income, and cash assets of $14.7 billion. ARRAYit will report the revenue and earnings from the Google sale in the fourth quarter of the year.

About ARRAYit Corporation                           

ARRAYit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company's innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. ARRAYit's products are used by every major research center in the world.

About Liston Street Pulse                                                 

Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Subscribe here to read more about ARYC, including CEO interviews.

Safe Harbor Statement

Except for historical information contained herein, statements made in this release that constitute forward-looking statements are based on currently available information, involve certain risks and uncertainties and the Company assumes no responsibility to update any such forward-looking statement. The following factors, among others, may cause actual results to differ materially from the results suggested in the forward-looking statements. Risks that may result from changes in the Company's business operations; our ability to keep pace with technological advances; significant competition in the biomedical business; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; non-availability of product; excess inventory; price and product competition; new product introductions, the outcome of our legal disputes; the possibility that the review of our prior filings by the SEC may result in changes to our financial statements; and the possibility that stockholders or regulatory authorities may initiate proceedings against ARRAYit and/or our officers and directors as a result of any restatements. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and Form 10-Q for the fiscal first quarter ended March 31, 2013, Form 10-Q for the fiscal second quarter ended June 30, 2013.

Sources:

www.arrayit.com 

www.listonstreetpulse.com


'/>"/>
SOURCE ARRAYit Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
2. Arrayit on Major Fundraising Drive
3. Genentech Purchases Arrayit Technology
4. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
7. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
8. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
9. Luminex Corporation Reports First Quarter 2012 Results
10. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
11. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):